{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:28:53Z","timestamp":1785540533270,"version":"3.56.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.neulet.2024.137750","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T17:51:50Z","timestamp":1711475510000},"page":"137750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Azoles display promising anticonvulsant effects through possible PPAR-\u03b1 activation"],"prefix":"10.1016","volume":"828","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8248-4218","authenticated-orcid":false,"given":"Suat","family":"Sari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel","family":"Yurto\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Zengin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Marcinkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Siwek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Sara\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.neulet.2024.137750_b0005","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2174\/156802612800229215","article-title":"Recent progress in anticonvulsant drug research: strategies for anticonvulsant drug development and applications of antiepileptic drugs for non-epileptic central nervous system disorders","volume":"12","author":"Dalkara","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.neulet.2024.137750_b0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.nurt.2006.11.010","article-title":"Molecular targets for antiepileptic drug development","volume":"4","author":"Meldrum","year":"2007","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.neulet.2024.137750_b0015","doi-asserted-by":"crossref","first-page":"e64541","DOI":"10.1371\/journal.pone.0064541","article-title":"PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings","volume":"8","author":"Puligheddu","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.neulet.2024.137750_b0020","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1517\/13543776.2013.782394","article-title":"Anticonvulsant\/antiepileptic carbonic anhydrase inhibitors: a patent review","volume":"23","author":"Aggarwal","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"issue":"4","key":"10.1016\/j.neulet.2024.137750_b0025","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1471-4159.2006.04277.x","article-title":"Serotonin and epilepsy","volume":"100","author":"Bagdy","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2024.137750_b0030","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fphys.2014.00172","article-title":"Roles of gap junctions, connexins, and pannexins in epilepsy","volume":"5","author":"Mylvaganam","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.neulet.2024.137750_b0035","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1007\/s00044-012-9972-6","article-title":"Imidazole as an anti-epileptic: an overview","volume":"21","author":"Mishra","year":"2012","journal-title":"Med. Chem. Res."},{"issue":"10","key":"10.1016\/j.neulet.2024.137750_b0040","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1073\/pnas.91.10.4569","article-title":"The modulatory action of loreclezole at the gamma-aminobutyric acid type a receptor is determined by a single amino acid in the beta 2 and beta 3 subunit","volume":"91","author":"Wingrove","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neulet.2024.137750_b0045","series-title":"Recent Advances in Epilepsy Research","first-page":"92","article-title":"GABA and its receptors in epilepsy","author":"Sperk","year":"2004"},{"issue":"5","key":"10.1016\/j.neulet.2024.137750_b0050","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/ddr.21538","article-title":"Synthesis, in vivo anticonvulsant testing, and molecular modeling studies of new nafimidone derivatives","volume":"80","author":"Acar","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.neulet.2024.137750_b0055","doi-asserted-by":"crossref","unstructured":"S. Sari, S. Dalkara, F.B. Kaynak, J. Reynisson, S. Sara\u00e7, A. Karakurt, New Anti-Seizure (Arylalkyl)azole Derivatives: Synthesis, In Vivo and In Silico Studies, Arch. Pharm. (Weinheim) 350 (6) (2017). Doi: 10.1002\/ardp.201700043.","DOI":"10.1002\/ardp.201700043"},{"issue":"6","key":"10.1016\/j.neulet.2024.137750_b0060","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.pharep.2018.06.007","article-title":"Synthesis and anticonvulsant screening of 1,2,4-triazole derivatives","volume":"70","author":"Sari","year":"2018","journal-title":"Pharmacol. Rep."},{"issue":"3","key":"10.1016\/j.neulet.2024.137750_b0065","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","article-title":"Pharmacological characterization of the 6 hz psychomotor seizure model of partial epilepsy","volume":"47","author":"Barton","year":"2001","journal-title":"Epilepsy Res."},{"issue":"1\u20132","key":"10.1016\/j.neulet.2024.137750_b0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02229077","article-title":"The early identification of anticonvulsant activity: role of the maximal electroshock and subcutaneous pentylenetetrazol seizure models","volume":"16","author":"White","year":"1995","journal-title":"Ital. J. Neurol. Sci."},{"key":"10.1016\/j.neulet.2024.137750_b0075","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ejmech.2019.06.083","article-title":"Discovery of new azoles with potent activity against Candida spp. and Candida albicans biofilms through virtual screening","volume":"179","author":"Sari","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"18","key":"10.1016\/j.neulet.2024.137750_b0080","doi-asserted-by":"crossref","first-page":"e202300134","DOI":"10.1002\/slct.202300134","article-title":"Design, synthesis, and Molecular modeling of new and safe azole oxime esters with promising antifungal activity","volume":"8","author":"Yurto\u011flu","year":"2023","journal-title":"ChemistrySelect"},{"issue":"2037","key":"10.1016\/j.neulet.2024.137750_b0085","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1126\/science.79.2037.38","article-title":"The method of probits","volume":"79","author":"Bliss","year":"1934","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.neulet.2024.137750_b0090","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field Accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.neulet.2024.137750_b0095","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neulet.2024.137750_b0100","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3389\/fphar.2017.00889","article-title":"vNN web server for ADMET predictions","volume":"8","author":"Schyman","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.neulet.2024.137750_b0105","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/ci500004h","article-title":"AlzPlatform: an Alzheimer's disease domain-specific chemogenomics knowledgebase for polypharmacology and target identification research","volume":"54","author":"Liu","year":"2014","journal-title":"J. Chem. Inf. Model."},{"issue":"8","key":"10.1016\/j.neulet.2024.137750_b0110","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/bioinformatics\/btaa918","article-title":"LightBBB: computational prediction model of blood-brain-barrier penetration based on LightGBM","volume":"37","author":"Shaker","year":"2021","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.neulet.2024.137750_b0115","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1021\/jm9016812","article-title":"Discovery of an oxybenzylglycine based Peroxisome proliferator activated receptor \u03b1 selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453)","volume":"53","author":"Li","year":"2010","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.neulet.2024.137750_b0120","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.neulet.2024.137750_b0125","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/ph14101025","article-title":"Repurposing Peroxisome proliferator-activated receptor agonists in neurological and psychiatric Disorders","volume":"14","author":"Sagheddu","year":"2021","journal-title":"Pharmaceuticals (basel)"},{"issue":"5","key":"10.1016\/j.neulet.2024.137750_b0130","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"issue":"8","key":"10.1016\/j.neulet.2024.137750_b0135","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0969-2126(01)00634-7","article-title":"Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family","volume":"9","author":"Cronet","year":"2001","journal-title":"Structure"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394024001277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394024001277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T08:06:44Z","timestamp":1713168404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394024001277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":27,"alternative-id":["S0304394024001277"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2024.137750","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azoles display promising anticonvulsant effects through possible PPAR-\u03b1 activation","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2024.137750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"137750"}}